SOUTH SAN FRANCISCO, Calif. - Drug developer Sunesis Pharmaceuticals Inc. said Thursday it was profitable in the first quarter after receiving a payment from partner Millennium Pharmaceuticals. Sunesis reported net income of $1.8 million, or 4 cents per...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Sunesis posts 1Q profit on Millennium payment
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account